Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982520priorityCriticalpatent/ECSP982520A/en
Publication of ECSP982520ApublicationCriticalpatent/ECSP982520A/en
La presente invención describe una composición farmacéutica que comprende compuesto (I), caracterizado porque la composición comprende de 2 a 12 mg de compuesto (I) en una forma farmacéuticamente aceptable y opcionalmente un vehículo farmacéuticamente aceptable para el mismo, la utilización del tal composición en medicina, un procedimiento para la preparación del tal composición, y una composición intermedia útil en tal procedimiento.The present invention describes a pharmaceutical composition comprising compound (I), characterized in that the composition comprises from 2 to 12 mg of compound (I) in a pharmaceutically acceptable form and optionally a pharmaceutically acceptable carrier therefor, the use of such composition in medicine, a procedure for the preparation of such a composition, and an intermediate composition useful in such a procedure.
Spontaneously dispersible pharmaceutical composition for oral administration comprising n-benzoyl-staurosporine; method to increase levels of bioavailability. (divisional of only 333-00).
LACTAMA COMPOUND (N) - ((S) -2-HIDROXI-3-METHYLBUTIRILE) -1- (L-ALANINIL) - (S) -1-AMINO-3-METHYL-4,5,6,7-TETRAHYDRO -2H-3-BENZAZEPIN-2-ONA, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, PROCEDURE FOR THE INHIBITION OF THE B-AMYLOID PEPTIDE RELEASE AND / OR ITS SYNTHESIS THAT USES IT AND ITS USE FOR THE FABR
PHARMACEUTICAL COMPOSITION CONTAINING 3-2 (DIMETHYLAMINE) ETHYL-N-METHYL-1H-INDOL-5-METHANE SULPHONAMIDE, RELATIVE PROCEDURE FOR PREPARATION AND USE OF THE SAME IN TREATMENT OF MAMMALS
USE OF CLORPROMAZINE AND PENTAMIDINE FOR THE MANUFACTURE OF MEDICINES, PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL PACKAGE THAT INCLUDE CHLORPROMAZINE AND PENTAMIDINE.
DERIVATIVE OF NAFTIRIDIN-DIBENZO [A, D] CICLOHEPTENO-10-ACETICO, PHARMACEUTICAL COMPOSITION, AND THE USE OF THAT DERIVATIVE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT.